|
Breast Cancer Index (BCI) prognostic and predictive classification in older versus younger patients with early-stage HR+ breast cancer (BC) and correlation with clinical risk factors. |
|
|
No Relationships to Disclose |
|
|
Employment - Cao Pharmaceuticals |
Leadership - Cao Pharmaceuticals (I) |
|
|
Employment - bioTheranostics |
Stock and Other Ownership Interests - bioTheranostics |
|
|
Employment - bioTheranostics |
Stock and Other Ownership Interests - bioTheranostics |
|
|
Employment - Biotheranostics |
Leadership - Biotheranostics |
Stock and Other Ownership Interests - Biotheranostics |
|
|
Consulting or Advisory Role - Boehringer Ingelheim; GTx; On Q Health; OptumHealth; Sanofi; Seagen |
Research Funding - Celgene; GlaxoSmithKline; Novartis |